![](/img/cover-not-exists.png)
Updated report: A randomized, double-blind, placebo-controlled phase II study of prophylactic dexamethasone (dex) therapy for fatigue and malaise due to regorafenib in patient (pts) with metastatic colorectal cancer (mCRC): (KSCC1402/HGCSG1402)
Yuki, S., Komatsu, Y., Satake, H., Miyamoto, Y., Tanioka, H., Tsuji, A., Asayama, M., Shiraishi, T., Kotaka, M., Makiyama, A., Kashiwada, T., Takeuchi, N., Shimokawa, M., Saeki, H., Oki, E., Emi, Y.,Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw370.95
Date:
October, 2016
File:
PDF, 40 KB
english, 2016